NCT06248684

Brief Summary

Prevention of Postoperative Delirium in the care of Elderly Patients. A Monocentric, Prospective Intervention Study With the Question of Whether the Incidence, Length and Severity of Postoperative Delirium Can be Reduced by Implementing a Standardised, Multidimensional Delirium Management Protocol.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15,000

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Feb 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Feb 2024Dec 2026

First Submitted

Initial submission to the registry

October 1, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

February 6, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 8, 2024

Status Verified

January 1, 2024

Enrollment Period

2.4 years

First QC Date

October 1, 2023

Last Update Submit

February 5, 2024

Conditions

Keywords

delirium, prevention and controlpost operative deliriumdelirium, risk factorsdelirium, risk assessmentBaseline-EEGcognitive testsEEG, intraoperative

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative delirium

    Patients are examined once per shift for the described duration postoperatively using validated tests for delirium (CAM-ICU or 3D-CAM). Delirium testing is supplemented by pain assessment using the numerical rating scale (NRS).

    for three days postoperatively and if the patient is delirium positive on the last day for the period until he is delirium negative or discharged from inpatient care, up to the day 90 visit at the latest

Secondary Outcomes (8)

  • duration of postoperative delirium

    for three days postoperatively and if the patient has delirium on the last day for the period until he is delirium negative or discharged from inpatient care, up to the day 90 visit at the latest

  • Severity of the postoperative delirium

    for three days postoperatively and if the patient has delirium on the last day for the period until he is delirium negative or discharged from inpatient care, up to the day 90 visit at the latest

  • Which parameters and tests detect patients at risk for postoperative delirium?

    From the time of premedication until three days postoperatively

  • Can baseline and intraoperative EEG parameters be used to identify patients at risk? Does intraoperative burst suppression EEG represent a risk factor for delirium?

    From the patient's arrival in the operating room to three days postoperatively

  • When is the diagnosis of postoperative delirium most commonly made?

    for three days postoperative

  • +3 more secondary outcomes

Study Arms (1)

prevention group

OTHER

patients receive standardized perioperative care using Standard Operating Procedures (SOPs) in accordance with the guidelines of the professional societies for the prevention of postoperative delirium.

Other: standardized prevention and therapy measures

Interventions

Patients from the age of 65 years with an additional risk factor for postoperative delirium are assigned to a multidimensional standardized perioperative care protocol.

prevention group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • \>= 65 Years
  • intervention in one of the following departments: general and visceral surgery, urology, vascular surgery, orthopedics, trauma surgery,
  • Written consent by patient or legal guardian

You may not qualify if:

  • Foreign language patients without interpreter
  • non-consenting patients without a legal representative

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Emergence DeliriumDelirium

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Gerhard Prof. Dr. med. Schneider, MD

    clinic for anesthesiology and intensive care, Klinikum rechts der Isar, Technical University Munich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gerhard Prof. Dr. med. Schneider, MD

CONTACT

Stefanie PD Dr. med. Pilge, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2023

First Posted

February 8, 2024

Study Start

February 6, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 8, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share